NANOFORM FINLAND OY
502082-7530ActiveNanoforming technology enhances drug performance across development stages.
Oversigt
- 1–4
- Medarbejdere
- Ukendt
- Omsætning
- 2019
- Grundlagt
Nøglebeslutningstagere
David Rowe
Head of Manufacturing
Christian Jones
Chief Commercial Officer
Antonio Da Silva
Manager
Albert Hæggström
Manager
+1 flere kontakter i Funnelfeedr
Beskrivelse
Nanoform is a pioneering pharmaceutical technology company specializing in advanced particle engineering services. They utilize their proprietary Controlled Expansion of Supercritical Solutions (CESS ®) process to transform drug formulations. Their core offering, nanoforming, enables pharmaceutica...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502082753001
Beslutningstagere
5 kontakter i FunnelfeedrDavid Rowe
Head of Manufacturing
Christian Jones
Chief Commercial Officer
Antonio Da Silva
Manager
Albert Hæggström
Manager
Peter Hänninen
Manager
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrDisruptive Pharma Operations AB
Transforming oral drugs via proprietary bioavailability enhancement technology.
RegenCura AB
1 medarbejdereCommercializing sustainable antimicrobial surfaces and advanced pollutant removal technology.
Veltio Pharma AB
3 medarbejdereProprietary platform enhances poorly soluble drug bioavailability using cellulose.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
DELSITECH OY
Developing silica-based drug delivery technology for long-acting injectables.
Udforsk mere
Spørgsmål om NANOFORM FINLAND OY
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo